BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31091004)

  • 1. Issue Highlights - May 2019.
    Orfao A
    Cytometry B Clin Cytom; 2019 May; 96(3):177-180. PubMed ID: 31091004
    [No Abstract]   [Full Text] [Related]  

  • 2. Computational Flow Cytometry Accurately Identifies Sezary Cells Based on Simplified Aberrancy and Clonality Features.
    Seheult JN; Weybright MJ; Jevremovic D; Shi M; Olteanu H; Horna P
    J Invest Dermatol; 2024 Jul; 144(7):1590-1599.e3. PubMed ID: 38237727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry for the diagnosis of mycosis fungoides.
    Meyerson HJ
    G Ital Dermatol Venereol; 2008 Feb; 143(1):21-41. PubMed ID: 18833049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural morphometry in the diagnosis of mycosis fungoides and Sézary's syndrome.
    Payne CM
    Clin Dermatol; 1991; 9(2):187-203. PubMed ID: 1747854
    [No Abstract]   [Full Text] [Related]  

  • 5. New aspects of the clinicopathological features and treatment of mycosis fungoides and Sézary syndrome.
    Furue M; Kadono T
    J Dermatol; 2015 Oct; 42(10):941-4. PubMed ID: 26432429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotyping on simultaneously occurring plaques and tumours in mycosis fungoides and Sézary syndrome.
    Preesman AH; Toonstra J; van der Putte SC; van Vloten WA
    Br J Dermatol; 1993 Dec; 129(6):660-6. PubMed ID: 8286248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotyping of acute leukemias and myelodysplastic syndromes.
    Orfao A; Ortuño F; de Santiago M; Lopez A; San Miguel J
    Cytometry A; 2004 Mar; 58(1):62-71. PubMed ID: 14994223
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter to the editor with regard to the article entitled "Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping".
    Roelens M; de Masson A; Ram-Wolff C; Bagot M; Moins-Teisserenc H
    Cytometry B Clin Cytom; 2021 Mar; 100(2):139-140. PubMed ID: 33031631
    [No Abstract]   [Full Text] [Related]  

  • 9. Authors reply to the letter to editor with regard to the article titled "Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping".
    Almeida J; Pulitzer MP; Horna P
    Cytometry B Clin Cytom; 2021 Mar; 100(2):141. PubMed ID: 33166040
    [No Abstract]   [Full Text] [Related]  

  • 10. Mycosis fungoides/Sézary syndrome: report of an unusual case.
    Mehta A; Dhungel BM; Khan MF
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():12-5. PubMed ID: 16972946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node histopathology in mycosis fungoides and Sézary's syndrome.
    Scheffer E; Meijer CJ; Willemze R; van Vloten WA
    Curr Probl Dermatol; 1990; 19():105-13. PubMed ID: 2404671
    [No Abstract]   [Full Text] [Related]  

  • 12. Simplified flow cytometric assessment in mycosis fungoides and Sézary syndrome.
    Hristov AC; Vonderheid EC; Borowitz MJ
    Am J Clin Pathol; 2011 Dec; 136(6):944-53. PubMed ID: 22095381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.
    Cazzola M
    Haematologica; 2009 Aug; 94(8):1041-3. PubMed ID: 19644135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidermotropic T lymphomas].
    Sigal-Nahum M; Brousse N; Belaïch S
    Rev Prat; 1987 May; 37(25):1423-31. PubMed ID: 3495856
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mycosis fungoides and Sézary syndrome: diagnostic and prognostic relevance of cellular antigen expression].
    Meissner K; Löning T; Rehpenning W
    Hautarzt; 1991 Feb; 42(2):84-91. PubMed ID: 2037492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [T gamma-lymphocytosis: a lymphoproliferative disease or reactive state].
    Zaritskiĭ AIu; Pozniak EI; Tsveĭbakh AS; Simbirtseva NIu; Ivasenko IN
    Vopr Onkol; 1986; 32(4):11-25. PubMed ID: 3518236
    [No Abstract]   [Full Text] [Related]  

  • 17. The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells.
    Bernengo MG; Novelli M; Quaglino P; Lisa F; De Matteis A; Savoia P; Cappello N; Fierro MT
    Br J Dermatol; 2001 Jan; 144(1):125-35. PubMed ID: 11167693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG anti-50 kd lymphocyte membrane peptide antibody in patients with Sézary syndrome.
    D'Ambra-Cabry K; Tharp MD; Jagasothy BV; Deng JS
    J Am Acad Dermatol; 1996 May; 34(5 Pt 1):777-80. PubMed ID: 8632073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research in morphology and flow cytometry is at the heart of hematology.
    Béné MC; Zini G;
    Haematologica; 2017 Mar; 102(3):421-422. PubMed ID: 28250005
    [No Abstract]   [Full Text] [Related]  

  • 20. The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome.
    Bi MY; Curry JL; Christiano AM; Hordinsky MK; Norris DA; Price VH; Duvic M
    J Am Acad Dermatol; 2011 Jan; 64(1):53-63. PubMed ID: 21036417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.